drugset / Trial / NCT06807554

Intraperitoneal Ketamine Versus Bupivacaine for Postoperative Pain Control After Laparoscopic Cholecystectomy

NCT06807554 ↗

Phase 0 Completed 92 enrolled Liaquat National Hospital & Medical College
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The intraperitoneal approach is used in anesthesia to manage the pain associated with abdominal procedures. Few studies have been conducted comparing intraperitonela ketamine with bupivacaine for pain control in laparoscopic cholecystectomy (LC) patients. To compare effect of intraperitoneal ketamine versus bupivacaine for postoperative pain control after LC. Department of Anesthesiology, Critical Care and Pain Management, Liaquat National Hospital and Medical College, Karachi. Group K received ketamine whereas Group B received bupivacaine. In Group K, ketamine 0.25mg/kg diluted in normal saline to a total volume of 40 ml was instilled by the surgeon. In Group B, bupivacaine 2mg/kgdiluted in normal saline to a total volume of 40ml was administered. Tramadol 1.5 mg/kg to a maximum of 100 mg IV was given as rescue analgesia. The pain was assessed using a numeric rating scale (NRS) with zero being no pain to ten being the worst possible pain. Pain was assessed using NRS at 0 hour (immediate postoperative period), 2 hour, 4 hour, 6 hour and 12 hours postoperatively.

Timeline

Start
2022-01-01
Primary completion
2022-01-01
Completion
2022-07-01

Outcome

Met primary endpoint

paper At 5 min, the average pain score was 2.1 ± 0.5 in Group K and 2.8 ± 0.7 in Group B (p < 0.001). PMID 41087934 ↗

paper intraperitoneal instillation of ketamine at a dose of 0.25 mg/kg was superior to bupivacaine alone PMID 41087934 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 2 mg/kg Other
Subject Ketamine Small molecule 0.25 mg/kg Other

Indications

No indication recorded.